Fortis Healthcare Limited (FORTIS.NS)
| Previous Close | 597.40 |
| Open | 593.20 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 574.00 - 596.00 |
| 52 Week Range | 313.80 - 628.50 |
| Volume | |
| Avg. Volume | 1,774,977 |
| Market Cap | 438.933B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | 67.14 |
| EPS (TTM) | 8.66 |
| Earnings Date | Nov 08, 2024 - Nov 12, 2024 |
| Forward Dividend & Yield | 1.00 (0.17%) |
| Ex-Dividend Date | Jul 24, 2024 |
| 1y Target Est | 527.85 |
- Reuters
UPDATE 1-IHH Healthcare unit sues Japan's Daiichi Sankyo over Fortis deal
Malaysia's IHH Healthcare on Tuesday said its unit filed a claim against Japan's Daiichi Sankyo in mid-October seeking damages in excess of 20 billion yen ($131.86 million) in relation to its stake buy in India's Fortis Healthcare. On Oct, 16, Northern TK Venture filed a claim against the Japanese pharmaceuticals manufacturer stating it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018. IHH Healthcare in December 2018 halted its open offer to buy an additional 26% stake in Fortis after a court ruling ordered status quo to be maintained after Daiichi filed a contempt plea against Fortis founders, according to media reports.
The Motley FoolFTS Stock: Buy, Sell or Hold?
Here's why long-term investors may want to consider Fortis (TSX:FTS) stock, given the company's impressive total shareholder returns. The post FTS Stock: Buy, Sell or Hold? appeared first on The Motley Fool Canada.
